Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership
ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals
HHS, NIH Prepare for Government Shutdown
FDA Approves Generic Capecitabine
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO